N@N

Market Maker Surveillance Report. TTNP, THLD, TISI, BTX, PACB, PAMT, Winning Stocks With Lowest Price Friction For Tuesday, Ja

January 8, 2013 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 3949 companies with "abnormal" market making, 2552 companies with positive Friction Factors and 2778 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Tuesday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Titan Pharmaceuticals Inc (OTC:TTNP), Threshold Pharmaceuticals Inc (NASDAQ:THLD), TEAM, INC. (NASDAQ:TISI), Biotonix (2010) Inc (AMEX:BTX), Pacific Biosciences of California Inc (NASDAQ:PACB), Parametric Sound Corp (NASDAQ:PAMT). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  TTNP    $0.230    16.20%    770,229      59.87%    409,236      31.81%    360,993      15,695  
  THLD    $0.610    14.35%    1,071,564    56.47%    826,026      43.53%    245,538      4,025   
  TISI    $4.790    12.91%    256,047      40.36%    194,339      30.63%    61,708       129     
  BTX     $0.430    12.46%    241,903      41.59%    151,851      26.11%    90,052       2,094   
  PACB    $0.320    17.81%    431,011      56.62%    327,484      43.02%    103,527      3,235   
  PAMT    $0.980    11.89%    94,407       51.92%    86,595       47.63%    7,812        80      

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net buy volumes (buy volume, sell volume) and low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows TTNP with a dollar gain Tuesday of $0.23000 and a Friction Factor of 15,695 shares. That means that it only took 15,695 more shares of buying than selling to move TTNP higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.

Titan Pharmaceuticals Inc (OTC:TTNP) - Titan Pharmaceuticals, Inc., a biopharmaceutical company, engages in developing proprietary therapeutics primarily for the treatment of central nervous system disorders in the United States. Its principal asset is Probuphine, a slow release implant formulation of buprenorphine to maintain a stable blood level of the medicine in patients for six months following a single treatment. The Probuphine utilizes the company s novel, proprietary drug delivery technology, ProNeura, which is used in developing products for the treatment of other chronic conditions, such as Parkinson s disease. The company also offers Fanapt (iloperidone), an atypical antipsychotic compound for the treatment of adult patients with schizophrenia for the treatment of schizophrenia. Titan Pharmaceuticals, Inc. was founded in 1992 and is based in South San Francisco, California..

Threshold Pharmaceuticals Inc (NASDAQ:THLD) - Threshold Pharmaceuticals, Inc., a development stage company, focuses on the discovery and development of drugs for the microenvironment of solid tumors and the bone marrows of hematologic malignancies as novel treatments for patients living with cancer. Its clinical development products include TH-302, a novel drug candidate, which is in Phase I, Phase II, and Phase III clinical trials for the severe hypoxic regions present in various solid tumors and hematologic malignancies. The company has a license and co-development agreement with Merck KGaA for the development and commercialization of TH-302; and license agreement with Eleison Pharmaceuticals, Inc. to develop and commercialize glufosfamide for the treatment of cancer in humans and animals. Threshold Pharmaceuticals, Inc. was founded in 2001 and is headquartered in South San Francisco, California..

TEAM, INC. (NASDAQ:TISI) - Team, Inc. provides specialty maintenance and construction services for maintaining high temperature and high pressure piping systems and vessels that are primarily utilized in heavy industries. It offers inspection and assessment services, such as inspection and evaluation of piping, piping components, and equipment; field heat treating services, including electric resistance and gas-fired combustion; leak repair services comprising on-stream repairs of leaks in pipes, valves, flanges, and other parts of piping systems and related equipment; and fugitive volatile organic chemical emission leak detection services consisting of identification, monitoring, data management, and reporting. The company also provides hot tapping services, such as hot tapping, Line-stop, and Freeze-stop services; field machining services, including the use of portable machining equipment to repair or modify machinery, equipment, vessels, and piping systems, as well as flange facing, pipe cutting, line boring, journal turning, drilling, and milling services; and technical bolting services comprising the use of hydraulic or pneumatic equipment with bolt tightening techniques for leak-free connections following plant maintenance and expansion projects, as well as bolt disassembly and hot bolting services. In addition, it offers field valve repair services consisting of on-site repairs to manual and control valves, and pressure and safety relief valves, as well as specialty valve actuator diagnostics and repair services. The company markets its services to companies in various heavy industries, which include petrochemical, refining, power, pipeline, steel, pulp and paper, and shipbuilding, as well as to municipalities, original equipment manufacturers, distributors, and engineering and construction firms. It operates primarily in the United States, Canada, and Europe. The company was founded in 1973 and is headquartered in Alvin, Texas..

Biotonix (2010) Inc (AMEX:BTX) - BioTime, Inc., a biotechnology company, focuses on regenerative medicine and blood plasma volume expanders. The company primarily focuses on regenerative medicine, which refers to therapies based on human embryonic stem cell and induced pluripotent stem cell technology designed to rebuild cell and tissue function lost due to degenerative disease or injury. It develops and markets research products in the field of stem cells and regenerative medicine, including an array of proprietary PureStem cell lines, HyStem hydrogels, culture media, and differentiation kits, as well as offers Hextend, a blood plasma volume expander. The company is developing Renevia, a biocompatible, implantable hyaluronan, and collagen-based matrix for cell delivery in human clinical applications; therapeutic products derived from stem cells for the treatment of retinal and neural degenerative diseases; and therapeutic applications of stem cells to treat orthopedic diseases and injuries. It is also developing PanC-Dx for the detection of cancer in blood samples; and applications of the company s proprietary induced pluripotent stem cell technology to reverse the developmental aging of human cells to treat cardiovascular and blood cell diseases. In addition, the company markets GeneCards, a human gene database. Further, it is developing an integrated database suite to complement GeneCards that would include the LifeMap database of embryonic development, stem cell research, and regenerative medicine, as well as MalaCards, the human disease database. BioTime, Inc. was founded in 1990 and is headquartered in Alameda, California..

Pacific Biosciences of California Inc (NASDAQ:PACB) - Pacific Biosciences of California, Inc., a development stage company, develops, manufactures, and markets an integrated platform for genetic analysis. The company engages in developing a technology platform that enables single molecule, real-time (SMRT) for the detection of biological processes. It primarily focuses on the deoxyribonucleic acid sequencing market. The company s product includes the PacBio RS, a sequencing platform, which consists of an instrument platform that uses its proprietary consumables, such as SMRT Cells and reagent kits. The company s customers include genome centers, genomics service providers, and agricultural companies, as well as clinical, government, and academic institutions. Pacific Biosciences of California, Inc. was founded in 2000 and is headquartered in Menlo Park, California..

Parametric Sound Corp (NASDAQ:PAMT) - Parametric Sound Corporation, a technology company, focuses on delivering audio solutions through its HyperSound (HSS) technology platform primarily in North America, Europe, and Asia. Its HSS technology generates sound along a directional ultrasonic column. The company s HSS-3000 product line delivers directed audio solutions to customers primarily for digital signage, point-of-purchase, in-store network, and related applications. Its technology are also used in commercial and consumer markets, including kiosks, electronic gaming, computers, video gaming, televisions, home audio, health care, movies and cinema, and mobile devices. Parametric Sound Corporation markets its products to commercial customers, integrators, and value added resellers to use its sound solution in their products and services, as well as to distributors. The company is headquartered in Poway, California..

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net

Contributing Sources

---